Drive Improvement in Screening Care and Outcomes

​

• Inform perinatal care providers of the trends and realities of observed mortality and morbidity related to: obstetrical hemorrhage, sepsis, and hypertensive conditions, mental health, and prenatal care access​

• Identify known interventions/guidelines/ approaches that reduce risk factors/likelihood of these outcomes​

• Collaborate with organizations and leaders to mobilize information effectively, change practice, and measure adherence to standards​

• Advocate for policy and program change, where necessary​

• ​Implement Fetal RHD screening to allow for targeted RhIG use and avoid overtreatment​

• Implement quality strategies and knowledge mobilization to support practice change re: appropriate use of RhIG​

• Measure RhIG use over time to demonstrate system savings​

• Embed a focus on equity of access to this screening in program design and ongoing monitoring​

• ​Mobilize knowledge to raise awareness among pregnant people and care providers regarding factors that can increase the risk, and how low-dose aspirin can mitigate ​
• Undertake an implementation/QI pilot to better understand how screening can be best situated (focus on primary care)​
• Keep health equity and impact at forefront of activities​

​In conjunction with Newborn Screening Ontario and provincial genetics program, co-design and submit proposal to MOH to fund a model for preconception and prenatal genetic carrier screening to evaluate the feasibility of a universal screening program as recommended in 2024 Health Technology Assessment. Model will propose:​

• Recommended testing technology and sample collection​

• Information management for highest clinical utility and quality assurance​

• Ethical, equitable, and pragmatic pilot segmentation (by population, geography, screening targets, or otherwise)​

• Assessment of patient acceptability of the screening program model(s)​

• Governance model over program structure and operations; evaluation schema; and ongoing program quality metrics